These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11422034)

  • 1. Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity.
    Kanbe T; Soma Y; Kawa Y; Kashima M; Mizoguchi M
    Br J Dermatol; 2001 Jun; 144(6):1148-53. PubMed ID: 11422034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.
    Kitoh T; Ishikawa H; Sawada S; Koshino K; Tokano Y; Hashimoto H; Nakagawa S
    Clin Rheumatol; 1998; 17(4):293-300. PubMed ID: 9776111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
    Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
    Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
    Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types.
    Hamza AM; Omar SS; Abo El-Wafa RA; Elatrash MJ
    Int J Dermatol; 2017 May; 56(5):534-539. PubMed ID: 28229452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.
    Makowska JS; Cieslak M; Kowalski ML
    BMC Pulm Med; 2009 Jun; 9():27. PubMed ID: 19480722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
    Gerdes S; Kurrat W; Mrowietz U
    Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.
    Czech W; Schöpf E; Kapp A
    Br J Dermatol; 1996 Jan; 134(1):17-21. PubMed ID: 8745880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels of interleukin 33 in patients with atopic dermatitis.
    Tamagawa-Mineoka R; Okuzawa Y; Masuda K; Katoh N
    J Am Acad Dermatol; 2014 May; 70(5):882-8. PubMed ID: 24569114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated SCF levels in the serum of patients with chronic renal failure.
    Kitoh T; Ishikawa H; Ishii T; Nakagawa S
    Br J Haematol; 1998 Sep; 102(5):1151-6. PubMed ID: 9753036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level of stem cell factor and its soluble receptor in aspirin-exacerbated respiratory disease.
    Kalmarzi RN; Foroutan A; Abdi M; Ataee P; Jalili A; Babaei E; Kashefi H; Mohamadi S; Sigari N; Kooti W
    Immunotherapy; 2019 Oct; 11(15):1283-1291. PubMed ID: 31530062
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
    Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
    J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble CD30 in patients with atopic dermatitis: correlations with age, disease duration and severity.
    El Mongy S; Metwaly SS; Arafat MS; Hady HA
    Egypt J Immunol; 2008; 15(1):123-9. PubMed ID: 20306677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the tumor necrosis factor family member LIGHT in the pathogenesis of atopic dermatitis.
    Seifeldin NS; El Sayed SB; Asaad MK; Aly AA
    Int J Dermatol; 2015 Oct; 54(10):e376-82. PubMed ID: 26043794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity.
    Shimada Y; Sato S; Hasegawa M; Tedder TF; Takehara K
    J Allergy Clin Immunol; 1999 Jul; 104(1):163-8. PubMed ID: 10400854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis.
    Katoh N; Hirano S; Suehiro M; Ikenaga K; Yasuno H
    Clin Exp Immunol; 2002 Feb; 127(2):283-8. PubMed ID: 11876751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.